Back to the main directory
EarningsReview / Equity
- Q2/H125 results: H1 LFL EBIT miss, but improved FY25 guidance by BNP Paribas Exane
- 2Q results first read by BNP Paribas Exane
- 2Q25 LFL strong, EBIT small ahead & unchanged guidance should support outperformance by BNP Paribas Exane
- 2Q25 results - Another strong beat supported by all P&L lines by BNP Paribas Exane
- H125 Results: Surprise guidance upgrade by BNP Paribas Exane
- Q2’25 Results first take: 10% EBIT miss and FY25 guidance confirmed by BNP Paribas Exane
- HY25 First Take: Big beat, bigger buyback by BNP Paribas Exane
- 1H25 first take - in-line EBITDA, no top up returns as expected, US listing not in the cards for now by BNP Paribas Exane
- H125 results: Nivea, W. Europe & Americas miss by BNP Paribas Exane
- H1-25 First Take by BNP Paribas Exane
- HY25: beat + confident cap gen outlook by BNP Paribas Exane
- H125 Results: ERV growth ahead of our expectations by BNP Paribas Exane
- GLEN, VOE, NDA by BNP Paribas Exane
- Kakao Games Corp (293490 KS) by HSBC
- French Telcos: More press reports on consolidation talks - key details, our own analysis, and sector readacross by BNP Paribas Exane
- H125 conf call: focus on H2 acceleration by BNP Paribas Exane
- Chevron (CVX US) by HSBC
- Q2/H125 results: Upbeat call despite mixed current trading by BNP Paribas Exane
- Off the call by BNP Paribas Exane
- Itaú BBA on RD Saúde: 2Q25: A Clean Beat by Itau
- 2Q25 Conf. Call Feedback by BNP Paribas Exane
- 九号公司（689009 CH） by HSBC
- Ninebot (689009 CH) by HSBC
- Nearing a €3bn deal in South Korea? by BNP Paribas Exane
- 东方雨虹（002271 CH） by HSBC